Pulmonary vascular disease

Clinical phenotyping of plasma thrombospondin-2 reveals relationship to right ventricular structure and function in pulmonary hypertension
Anna M. Dittrich, Julia Mienert, Julian Pott, Lena Engels, Christoph Sinning, Jan K. Hennigs, Hans Klose, Lars Harbaum

ERJ Open Research Mar 2023, 9 (2) 00528-2022; DOI: 10.1183/23120541.00528-2022
AV-101, a novel inhaled dry-powder formulation of imatinib, in healthy adult participants: a phase 1 single and multiple ascending dose study
Hunter Gillies, Ralph Niven, Benjamin T. Dake, Murali M. Chakinala, Jeremy P. Feldman, Nicholas S. Hill, Marius M. Hoeper, Marc Humbert, Vallerie V. McLaughlin, Martin Kankam

ERJ Open Research Mar 2023, 9 (2) 00433-2022; DOI: 10.1183/23120541.00433-2022
Decreased plasma levels of the brain-derived neurotrophic factor correlate with right heart congestion in pulmonary arterial hypertension
Katharina Schäfer, Khodr Tello, Oleg Pak, Manuel Richter, Mareike Gierhardt, Grazyna Kwapiszewska, Christine Veith, Ludger Fink, Henning Gall, Matthias Hecker, Baktybek Kojonazarov, Simone Kraut, Kevin Lo, Jochen Wilhelm, Friedrich Grimminger, Werner Seeger, Ralph T. Schermuly, Hossein A. Ghofrani, Daniel Zahner, Rüdiger Gerstberger, Norbert Weissmann, Akylbek Sydykov, Natascha Sommer

ERJ Open Research Mar 2023, 9 (2) 00230-2022; DOI: 10.1183/23120541.00230-2022
Pulmonary hypertension: the hallmark of acute COVID-19 microvascular angiopathy?
Sri Harsha Dintakurti, Sanjana Kamath, Ciara Mahon, Suveer Singh, Bhavin Rawal, Simon P.G. Padley, Anand Devaraj, Laura C. Price, Sujal R. Desai, Tom Semple, Carole A. Ridge

ERJ Open Research Jan 2023, 9 (1) 00389-2022; DOI: 10.1183/23120541.00389-2022
Computational platform for doctor–artificial intelligence cooperation in pulmonary arterial hypertension prognostication: a pilot study
Vitaly O. Kheyfets, Andrew J. Sweatt, Mardi Gomberg-Maitland, Dunbar D. Ivy, Robin Condliffe, David G. Kiely, Allan Lawrie, Bradley A. Maron, Roham T. Zamanian, Kurt R. Stenmark

ERJ Open Research Jan 2023, 9 (1) 00484-2022; DOI: 10.1183/23120541.00484-2022
Hyperoxia improves exercise capacity in cardiopulmonary disease A series of RCT's
Julian Müller, Mona Lichtblau, Stéphanie Saxer, Simon R. Schneider, Paula Appenzeller, Meret Bauer, Elisabeth D. Hasler, Esther I. Schwarz, Konrad E. Bloch, Silvia Ulrich

ERJ Open Research Jan 2023, 00563-2022; DOI: 10.1183/23120541.00563-2022
Pulmonary Hypertension and Measurement of Exercise Capacity Remotely: Evaluation of the 1-min Sit-to-Stand Test (PERSPIRE) – a cohort study
Carol Keen, Ian Smith, Molly Hashmi-Greenwood, Karen Sage, David G. Kiely

ERJ Open Research Jan 2023, 9 (1) 00295-2022; DOI: 10.1183/23120541.00295-2022
Early selexipag initiation and long-term outcomes: insights from randomised controlled trials in pulmonary arterial hypertension
J. Gerry Coghlan, Sean Gaine, Richard Channick, Kelly M. Chin, Camille du Roure, J. Simon R. Gibbs, Marius M. Hoeper, Irene M. Lang, Stephen C. Mathai, Vallerie V. McLaughlin, Lada Mitchell, Gérald Simonneau, Olivier Sitbon, Victor F. Tapson, Nazzareno Galiè

ERJ Open Research Jan 2023, 9 (1) 00456-2022; DOI: 10.1183/23120541.00456-2022
When more is more: the role of additional upfront therapy in pulmonary arterial hypertension
Shannon Niedermeyer, Paul Hassoun

ERJ Open Research Jan 2023, 9 (1) 00592-2022; DOI: 10.1183/23120541.00592-2022
Prognostic role of different findings at echocardiography in acute pulmonary embolism. A critical review and meta-analysis
Ludovica Anna Cimini, Matteo Candeloro, Magdalena Pływaczewska, Giorgio Maraziti, Marcello Di Nisio, Piotr Pruszczyk, Giancarlo Agnelli, Cecilia Becattini

ERJ Open Research Jan 2022, 00641-2022; DOI: 10.1183/23120541.00641-2022

Main menu

User menu

Search

Pulmonary vascular disease

Pages

Contact us